Catherine Friedman

Catherine J.
Friedman is the founder of Revolution Healthcare Acquisition Corp.
Current roles include Lead Independent Director at Lyell Immunopharma, Inc. since 2021, Trustee at Sacred Heart Schools Atherton, Trustee at The University of California, San Francisco, Trustee at Darden School Foundation, Executive Venture Partner at GV Management Co. LLC.
since 2022, and Trustee at the University of Virginia Darden School of Business.
.
Former roles include Managing Director & Head-West Coast Healthcare at Morgan Stanley from 1997 to 2006, Independent Director at Yahoo!, Inc. from 2016 to 2017, Independent Director at Radius Health, Inc. from 2015 to 2022, Independent Director at XenoPort, Inc. from 2011 to 2016, Independent Director at Innoviva, Inc. from 2014 to 2018, Director at EnteroMedics, Inc. from 2010 to 2016, Independent Director at SuRo Capital Corp.
from 2013 to 2017, Director at Vividion Therapeutics, Inc., Director at ReShape Weightloss, Inc., Independent Director at Seer, Inc. (California) from 2020 to 2023, Director at GRAIL, Inc. from 2017 to 2018, and Independent Director at Altaba Inc. from 2017 to 2026.
Education includes an undergraduate degree from Harvard University in 1982 and an MBA from the University of Virginia Darden School of Business in 1986.